These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 33101309)

  • 1. Emerging Concepts and Technologies in Vaccine Development.
    Brisse M; Vrba SM; Kirk N; Liang Y; Ly H
    Front Immunol; 2020; 11():583077. PubMed ID: 33101309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.
    Trovato M; Sartorius R; D'Apice L; Manco R; De Berardinis P
    Front Immunol; 2020; 11():2130. PubMed ID: 33013898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The race for coronavirus vaccines: a graphical guide.
    Callaway E
    Nature; 2020 Apr; 580(7805):576-577. PubMed ID: 32346146
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine development: Current trends and technologies.
    Poria R; Kala D; Nagraik R; Dhir Y; Dhir S; Singh B; Kaushik NK; Noorani MS; Kaushal A; Gupta S
    Life Sci; 2024 Jan; 336():122331. PubMed ID: 38070863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
    Samrat SK; Tharappel AM; Li Z; Li H
    Virus Res; 2020 Oct; 288():198141. PubMed ID: 32846196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological considerations for COVID-19 vaccine strategies.
    Jeyanathan M; Afkhami S; Smaill F; Miller MS; Lichty BD; Xing Z
    Nat Rev Immunol; 2020 Oct; 20(10):615-632. PubMed ID: 32887954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.
    Wolf J; Hansen R; Hassis K; Lapps W; Warmuth E
    Vaccine; 2020 Oct; 38(46):7198-7200. PubMed ID: 33032845
    [No Abstract]   [Full Text] [Related]  

  • 10. A systematic review of SARS-CoV-2 vaccine candidates.
    Dong Y; Dai T; Wei Y; Zhang L; Zheng M; Zhou F
    Signal Transduct Target Ther; 2020 Oct; 5(1):237. PubMed ID: 33051445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Genetic Vaccines the Right Weapon against COVID-19?
    Conforti A; Marra E; Roscilli G; Palombo F; Ciliberto G; Aurisicchio L
    Mol Ther; 2020 Jul; 28(7):1555-1556. PubMed ID: 32553431
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccines for COVID-19: The current state of play.
    Koirala A; Joo YJ; Khatami A; Chiu C; Britton PN
    Paediatr Respir Rev; 2020 Sep; 35():43-49. PubMed ID: 32653463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
    Yu J; Tostanoski LH; Peter L; Mercado NB; McMahan K; Mahrokhian SH; Nkolola JP; Liu J; Li Z; Chandrashekar A; Martinez DR; Loos C; Atyeo C; Fischinger S; Burke JS; Slein MD; Chen Y; Zuiani A; Lelis FJN; Travers M; Habibi S; Pessaint L; Van Ry A; Blade K; Brown R; Cook A; Finneyfrock B; Dodson A; Teow E; Velasco J; Zahn R; Wegmann F; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kirilova M; Kordana N; Lin Z; Maxfield LF; Nampanya F; Nityanandam R; Ventura JD; Wan H; Cai Y; Chen B; Schmidt AG; Wesemann DR; Baric RS; Alter G; Andersen H; Lewis MG; Barouch DH
    Science; 2020 Aug; 369(6505):806-811. PubMed ID: 32434945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
    Al-Kassmy J; Pedersen J; Kobinger G
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
    Nambulli S; Escriou N; Rennick LJ; Demers MJ; Tilston-Lunel NL; McElroy AK; Barbeau DJ; Crossland NA; Hoehl RM; Schrauf S; White AG; Borish HJ; Tomko JA; Frye LJ; Scanga CA; Flynn JL; Martin A; Gerke C; Hartman AL; Duprex WP
    J Virol; 2024 May; 98(5):e0176223. PubMed ID: 38563762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COVID-19 vaccine development landscape.
    Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S
    Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591
    [No Abstract]   [Full Text] [Related]  

  • 17. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine development and a potential nanomaterial path forward.
    Shin MD; Shukla S; Chung YH; Beiss V; Chan SK; Ortega-Rivera OA; Wirth DM; Chen A; Sack M; Pokorski JK; Steinmetz NF
    Nat Nanotechnol; 2020 Aug; 15(8):646-655. PubMed ID: 32669664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
    Alsulaiman JW; Khasawneh AI; Kheirallah KA
    J Infect Dev Ctries; 2020 Sep; 14(9):957-962. PubMed ID: 33031080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.